Alpha Tau Medical Stock Today

DRTS Stock  USD 2.27  0.03  1.34%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 30

 
High
 
Low
Below Average
Alpha Tau is selling for under 2.27 as of the 8th of November 2024; that is 1.34 percent increase since the beginning of the trading day. The stock's lowest day price was 2.24. Alpha Tau has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Alpha Tau Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of October 2024 and ending today, the 8th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
8th of March 2021
Category
Healthcare
Classification
Health Care
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of solid cancer In Israel and the United States. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. The company has 69.92 M outstanding shares of which 51.4 K shares are currently shorted by private and institutional investors with about 2.0 trading days to cover. More on Alpha Tau Medical

Moving against Alpha Stock

  0.47DRMA Dermata TherapeuticsPairCorr
  0.33VALN Valneva SE ADRPairCorr

Alpha Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic IdeaMedical Equipment (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Medical Equipment, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities4.2 M7.1 M
Way Down
Slightly volatile
Non Current Liabilities Total30.1 M15.8 M
Way Up
Very volatile
Total Assets77.9 M107.4 M
Way Down
Slightly volatile
Total Current Assets66.5 M85.8 M
Significantly Down
Slightly volatile
Debt Levels
Alpha Tau can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alpha Tau's financial leverage. It provides some insight into what part of Alpha Tau's total assets is financed by creditors.
Liquidity
Alpha Tau Medical currently holds 13.28 M in liabilities. Alpha Tau Medical has a current ratio of 41.14, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Alpha Tau's use of debt, we should always consider it together with its cash and equity.

Depreciation

655,820
Alpha Tau Medical (DRTS) is traded on NASDAQ Exchange in USA. It is located in Kiryat Hamada Street 5, Jerusalem, Israel, 9777605 and employs 121 people. Alpha Tau is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 160.13 M. Alpha Tau Medical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 69.92 M outstanding shares of which 51.4 K shares are currently shorted by private and institutional investors with about 2.0 trading days to cover. Alpha Tau Medical currently holds about 112.04 M in cash with (17.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.63.
Check Alpha Tau Probability Of Bankruptcy
Ownership Allocation
Alpha Tau holds a total of 69.92 Million outstanding shares. Alpha Tau Medical retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alpha Ownership Details

Alpha Stock Institutional Holders

InstituionRecorded OnShares
Caprock Group Inc2024-06-30
23.3 K
Northern Trust Corp2024-06-30
23.3 K
Aptus Capital Advisors, Llc2024-06-30
21.9 K
Tuttle Capital Management, Llc2024-09-30
12.2 K
Usadvisors Wealth Management, Llc2024-06-30
10.7 K
Opal Wealth Advisors, Llc2024-09-30
10 K
Steward Partners Investment Advisory, Llc2024-06-30
K
Tower View Investment Management & Research Llc2024-09-30
5.6 K
Royal Bank Of Canada2024-06-30
1.5 K
Easterly Investment Partners.2024-06-30
280.5 K
Hoylecohen, Llc2024-06-30
269.1 K
View Alpha Tau Diagnostics

Alpha Tau Historical Income Statement

At this time, Alpha Tau's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 5.1 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 891.9 K in 2024. View More Fundamentals

Alpha Stock Against Markets

Alpha Tau Corporate Management

Robert MDChief BoardProfile
Rebecca BeckerVice legalProfile
Pr KelsonChief BoardProfile
Yael ZeigerCorporate ControllerProfile
Raphi LevyChief OfficerProfile
Peter MelnykChief OfficerProfile
Pr KeisariChief boardProfile

Additional Tools for Alpha Stock Analysis

When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.